NDC Package 60505-6238-6 Deferoxamine Mesylate

Injection, Powder, Lyophilized, For Solution Intramuscular; Intravenous; Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
60505-6238-6
Package Description:
4 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON
Product Code:
Proprietary Name:
Deferoxamine Mesylate
Non-Proprietary Name:
Deferoxamine Mesylate
Substance Name:
Deferoxamine Mesylate
Usage Information:
This medication is used along with other treatments (such as causing vomiting with syrup of ipecac, stomach pumping) to treat sudden iron poisoning. It is most effective when given as soon as possible after the iron was eaten. This medication can also be used to help get rid of iron in patients with high iron levels due to many blood transfusions. Deferoxamine is an iron-binding agent that belongs to a class of drugs known as heavy metal antagonists. It works by helping the kidneys and gallbladder get rid of the extra iron. This medication is not recommended for use in children less than 3 years old (see also Precautions section).
11-Digit NDC Billing Format:
60505623806
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
4 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 1731350 - deferoxamine mesylate 500 MG Injection
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Apotex Corp.
    Dosage Form:
    Injection, Powder, Lyophilized, For Solution - A dosage form intended for the solution prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections.
    Administration Route(s):
  • Intramuscular - Administration within a muscle.
  • Intravenous - Administration within or into a vein or veins.
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    ANDA207384
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    03-28-2022
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 60505-6238-6 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    60505623806J0895Deferoxamine mesylate inj500 MG1414

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 60505-6238-6?

    The NDC Packaged Code 60505-6238-6 is assigned to a package of 4 injection, powder, lyophilized, for solution in 1 carton of Deferoxamine Mesylate, a human prescription drug labeled by Apotex Corp.. The product's dosage form is injection, powder, lyophilized, for solution and is administered via intramuscular; intravenous; subcutaneous form.This product is billed for "EA" each discreet unit and contains an estimated amount of 4 billable units per package.

    Is NDC 60505-6238 included in the NDC Directory?

    Yes, Deferoxamine Mesylate with product code 60505-6238 is active and included in the NDC Directory. The product was first marketed by Apotex Corp. on March 28, 2022 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 60505-6238-6?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 4.

    What is the 11-digit format for NDC 60505-6238-6?

    The 11-digit format is 60505623806. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-160505-6238-65-4-260505-6238-06